Skip to nav Skip to content
Facebook Twitter LinkedIn Email

IDSA and HIVMA on Updated PrEP Recommendations 

The Infectious Diseases Society of America and the HIV Medicine Association welcome the U.S. Preventive Services Task Force’s updated statement reaffirming and expanding its Grade A recommendation for pre-exposure prophylaxis for the prevention of HIV among adolescents and adults. The recommendation now covers all PrEP formulations, including long-acting injectable cabotegravir.

The strength of the evidence and the USPSTF’s recommendation highlight the importance and urgency in expanding PrEP access to all who could benefit from it. USPSTF’s affirmation of the efficacy of injectable PrEP will help make lifesaving preventive therapy accessible to more people. 

With the new recommendation, most health insurers will be required to cover all PrEP formulations provided that the Affordable Care Act’s preventive coverage benefit stands. Expanding PrEP is a priority if we are to end the HIV epidemic. Unfortunately, the current court challenge to the preventive services coverage requirement, if successful, would put more people at risk for HIV and other serious infectious diseases and would be a major setback to efforts to end HIV as an epidemic.

Carlos del Rio MD, FIDSA – President, Infectious Diseases Society of America
Michelle Cespedes, MD, MS – Chair, HIV Medicine Association  

About the Infectious Diseases Society of America
IDSA is a leader on issues of importance to ID professionals, including education and training, policy and advocacy, setting guidelines for patient care, and developing resources for clinical practice. It remains at the forefront of global health issues such as COVID-19, antimicrobial resistance and HIV/AIDS. Housed within IDSA is the HIV Medicine Association, which represents medical providers and researchers working on the front lines of HIV. More than 12,000 IDSA and HIVMA members work across the United States and in nearly 100 other countries on six different continents. For more information visit Follow IDSA on Facebook and Twitter. 

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.